Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis
暂无分享,去创建一个
D. Calvisi | L. Gómez-Quiroz | J. Marquardt | R. Hernández-Pando | A. Luna-López | L. Bucio | V. Souza | Cristina Enríquez-Cortina | A. Simoni-Nieves | Patricia Rosales-Cruz | Oscar Bello-Monroy | R. Miranda | M. Gutiérrez-Ruíz | R. Toledo-Pérez | Rafael Toledo-Pérez
[1] L. Terracciano,et al. Liver damage and senescence increases in patients developing hepatocellular carcinoma , 2017, Journal of gastroenterology and hepatology.
[2] Xiangjian Luo,et al. Emerging roles of lipid metabolism in cancer metastasis , 2017, Molecular Cancer.
[3] D. Calvisi,et al. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma , 2017, Cell cycle.
[4] D. Calvisi,et al. Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[5] Wen-Hong Wang,et al. Genetic alterations in hepatocellular carcinoma: An update , 2016, World journal of gastroenterology.
[6] L. Gómez-Quiroz,et al. Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice , 2016, Oxidative medicine and cellular longevity.
[7] J. Fernandez-Checa,et al. Mitochondria, cholesterol and cancer cell metabolism , 2016, Clinical and Translational Medicine.
[8] Isabel R Schlaepfer,et al. Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis , 2016, International journal of molecular sciences.
[9] S. Thorgeirsson,et al. Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress. , 2016, Toxicology.
[10] J. Dufour,et al. Surveillance for Hepatocellular Carcinoma in Patients with NASH , 2016, Diagnostics.
[11] Ji‐Xin Cheng,et al. Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer , 2016, Oncogene.
[12] Jie Liu,et al. Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells. , 2016, Oncology letters.
[13] L. Gómez-Quiroz,et al. Hepatocyte Growth Factor Reduces Free Cholesterol-Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress , 2016, Oxidative medicine and cellular longevity.
[14] S. Beloribi-Djefaflia,et al. Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.
[15] S. Costantini,et al. GPX4 and GPX7 Over-Expression in Human Hepatocellular Carcinoma Tissues , 2015, European journal of histochemistry : EJH.
[16] A. Ryan,et al. ATM and ATR as therapeutic targets in cancer. , 2015, Pharmacology & therapeutics.
[17] Lucas B. Sullivan,et al. Mitochondrial reactive oxygen species and cancer , 2014, Cancer & Metabolism.
[18] P. Schumacker,et al. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.
[19] H. Bartsch,et al. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts , 2014, Redox biology.
[20] H. Kalbacher,et al. De novo lipogenesis in health and disease. , 2014, Metabolism: Clinical and Experimental.
[21] D. Kershenobich,et al. Acetaldehyde targets superoxide dismutase 2 in liver cancer cells inducing transient enzyme impairment and a rapid transcriptional recovery. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[22] P. Nielsen,et al. Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. , 2014, Biochimica et biophysica acta.
[23] M. Kudo,et al. Reactive Oxygen Species Induce Epigenetic Instability through the Formation of 8-Hydroxydeoxyguanosine in Human Hepatocarcinogenesis , 2013, Digestive Diseases.
[24] L. Zou,et al. DNA damage sensing by the ATM and ATR kinases. , 2013, Cold Spring Harbor perspectives in biology.
[25] L. Gómez-Quiroz,et al. Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[26] S. Thorgeirsson,et al. Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. , 2013, Biochimie.
[27] A. Colell,et al. Hepatocarcinogenesis and ceramide/cholesterol metabolism. , 2012, Anti-cancer agents in medicinal chemistry.
[28] Fan Mo,et al. RNA-Seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma , 2011, PloS one.
[29] D. Calvisi,et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. , 2011, Gastroenterology.
[30] A. Zentella,et al. Bcl-2 sustains hormetic response by inducing Nrf-2 nuclear translocation in L929 mouse fibroblasts. , 2010, Free radical biology & medicine.
[31] H. Waldmann,et al. The lipid modifications of Ras that sense membrane environments and induce local enrichment. , 2009, Angewandte Chemie.
[32] J. Fernandez-Checa,et al. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. , 2009, Journal of hepatology.
[33] M. Nakanishi,et al. 8‐Hydroxy‐2′‐deoxy‐guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection , 2008, Journal of gastroenterology and hepatology.
[34] J. Prieto,et al. Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. , 2008, Cancer research.
[35] J. Hayashi,et al. ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.
[36] S. Thorgeirsson,et al. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis. , 2007, Cancer research.
[37] A. Richardson,et al. Gpx4 protects mitochondrial ATP generation against oxidative damage. , 2007, Biochemical and biophysical research communications.
[38] A. Colell,et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. , 2006, Cell metabolism.
[39] S. Thorgeirsson,et al. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. , 2006, The Journal of clinical investigation.
[40] Dimitris Kletsas,et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.
[41] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[42] R. Schiestl,et al. Effect of N-Acetyl Cysteine on Oxidative DNA Damage and the Frequency of DNA Deletions in Atm-Deficient Mice , 2004, Cancer Research.
[43] Ken‐ichi Yamamoto,et al. Protective roles for ATM in cellular response to oxidative stress , 2000, FEBS letters.
[44] Henry R. Bourne,et al. Lipid Modifications of Trimeric G Proteins (*) , 1995, The Journal of Biological Chemistry.
[45] S. Aust,et al. Microsomal lipid peroxidation. , 1978, Methods in enzymology.